This trial is being conducted to study the effects of an emerging endometriosis treatment, on cardiovascular function in women with endometriosis.
6 Primary · 3 Secondary · Reporting Duration: 5 days after treatment
Experimental Treatment
Non-Treatment Group
24 Total Participants · 2 Treatment Groups
Primary Treatment: Salsalate Pill · Has Placebo Group · Phase < 1
Age 18 - 45 · Female Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Massachusetts | 100.0% |
18 - 65 | 100.0% |
Did not meet criteria | 100.0% |